RSV Vaccinations Offered at Pharmacies

A leading pharmacy chain today announced it is offering respiratory syncytial virus (RSV) vaccination and testing appointments through about 9,000 locations in the U.S.

Walgreens Co. confirmed on August 1, 2023, eligible individuals ages 60 years and older can receive one of the U.S. FDA-approved RSV vaccines following a clinical discussion with a healthcare provider.

RSV vaccination appointments will be available at most locations during nights, weekends, and walk-ins.

"We know our trusted pharmacy teams will be relied upon this fall to prevent the spread of seasonal viruses, as patients see their pharmacist almost twice as often as their physician or other healthcare provider," said Rick Gates, Walgreens chief pharmacy officer, in a press release.

"All of us need to do our part to stay healthy, and neighborhood pharmacies are the most accessible destinations for the quick, routine, and preventative care that patients have come to expect post-pandemic."

For individuals experiencing sniffles, cough, or other respiratory symptoms, Walgreens neighborhood community pharmacists are equipped to offer testing options to help determine which respiratory virus is causing symptoms.

Walgreens will have several convenient options for testing, including rapid antigen tests that can detect COVID-19 and Flu A/B in one visit.

Globally, RSV activity was recently found to be generally low except in a few countries in the Region of the Americas, reported the World Health Organization Influenza Update N° 450. 

In the U.S., the annual RSV season generally is first detected in Florida. As of late July 2023, there are no RSV outbreaks in Florida's five regions. 

Prospective patients can visit the pharmacy or schedule an appointment through the Walgreens app or Walgreens.com/ScheduleVaccine or by calling 1-800-WALGREENS.

Note: This news article is not paid content.